2018
DOI: 10.1111/dme.13690
|View full text |Cite
|
Sign up to set email alerts
|

Nerve action potential amplitude, a robust marker of diabetic peripheral neuropathy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 10 publications
0
1
0
Order By: Relevance
“…Advanced glycation end products (AGEs) have been proven to be correlated with the development of diabetic complications [24,25]. Intensive studies have demonstrated that the formation of AGEs may play a role in the pathogenesis of diseases, such as impaired wound healing and diabetic neuropathy, and in diabetic retinopathy [26][27][28]. AGEs have been used to establish a cell model for the study of DFU and diabetic mesangium [29,30].…”
mentioning
confidence: 99%
“…Advanced glycation end products (AGEs) have been proven to be correlated with the development of diabetic complications [24,25]. Intensive studies have demonstrated that the formation of AGEs may play a role in the pathogenesis of diseases, such as impaired wound healing and diabetic neuropathy, and in diabetic retinopathy [26][27][28]. AGEs have been used to establish a cell model for the study of DFU and diabetic mesangium [29,30].…”
mentioning
confidence: 99%